L. I. Hart

403 total citations
10 papers, 334 citations indexed

About

L. I. Hart is a scholar working on Molecular Biology, Organic Chemistry and Nephrology. According to data from OpenAlex, L. I. Hart has authored 10 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Nephrology. Recurrent topics in L. I. Hart's work include Biochemical and Molecular Research (4 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Enzyme function and inhibition (2 papers). L. I. Hart is often cited by papers focused on Biochemical and Molecular Research (4 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Enzyme function and inhibition (2 papers). L. I. Hart collaborates with scholars based in United Kingdom, Switzerland and Canada. L. I. Hart's co-authors include Helen Chapman, R. C. Bray, Kenneth R. Harrap, Bridget T. Hill, D. Niethammer, Robert Jackson, Robert C. Bray, A H Calvert, C. Sessa and S.J. Harland and has published in prestigious journals such as Annals of the New York Academy of Sciences, Archives of Biochemistry and Biophysics and British Journal Of Nutrition.

In The Last Decade

L. I. Hart

10 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. I. Hart United Kingdom 6 192 59 50 47 43 10 334
Joscha Kotthaus Germany 12 161 0.8× 8 0.1× 60 1.2× 66 1.4× 31 0.7× 16 410
Bettina Wahl Germany 4 106 0.6× 8 0.1× 69 1.4× 124 2.6× 48 1.1× 5 295
Johanna Geissler Switzerland 9 271 1.4× 15 0.3× 110 2.2× 11 0.2× 6 0.1× 10 679
Debora Reichmann Germany 10 128 0.7× 12 0.2× 69 1.4× 128 2.7× 60 1.4× 12 339
Mary K. Wolpert United States 8 149 0.8× 5 0.1× 37 0.7× 5 0.1× 7 0.2× 10 272
Pia Lorentzon Sweden 11 328 1.7× 16 0.3× 130 2.6× 5 0.1× 10 0.2× 16 614
Judith M. Megaw United States 14 183 1.0× 11 0.2× 4 0.1× 9 0.2× 20 0.5× 23 411
Birte Plitzko Germany 10 160 0.8× 8 0.1× 43 0.9× 31 0.7× 26 0.6× 11 323
John D. Vavra United States 5 267 1.4× 112 1.9× 9 0.2× 30 0.7× 6 558
Ojia Skaff Australia 8 188 1.0× 9 0.2× 9 0.2× 9 0.2× 8 0.2× 8 466

Countries citing papers authored by L. I. Hart

Since Specialization
Citations

This map shows the geographic impact of L. I. Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. I. Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. I. Hart more than expected).

Fields of papers citing papers by L. I. Hart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. I. Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. I. Hart. The network helps show where L. I. Hart may publish in the future.

Co-authorship network of co-authors of L. I. Hart

This figure shows the co-authorship network connecting the top 25 collaborators of L. I. Hart. A scholar is included among the top collaborators of L. I. Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. I. Hart. L. I. Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sessa, C., et al.. (1985). The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717). Cancer Chemotherapy and Pharmacology. 14(3). 265–71. 39 indexed citations
2.
Jackman, Ann L., A H Calvert, L. I. Hart, & Kenneth R. Harrap. (1984). Inhibition of Thymidylate Synthetase by the New Quinazoline Antifolate, CB 3717; Enzyme Purification and Kinetics. Advances in experimental medicine and biology. 165 Pt B. 375–378. 5 indexed citations
3.
Browman, George P., A. Hilary Calvert, G. A. Taylor, L. I. Hart, & K.R. Harrap. (1980). The intracellular mechanism of action of metoprine (DDMP). European Journal of Cancer (1965). 16(12). 1547–1554. 4 indexed citations
4.
Jackson, Robert, D. Niethammer, & L. I. Hart. (1977). Reactivation of dihydrofolate reductase inhibited by methotrexate or aminopterin. Archives of Biochemistry and Biophysics. 182(2). 646–656. 41 indexed citations
5.
Harrap, Kenneth R., et al.. (1971). SITES OF ACTION OF AMETHOPTERIN: INTRINSIC AND ACQUIRED DRUG RESISTANCE*. Annals of the New York Academy of Sciences. 186(1). 312–324. 70 indexed citations
6.
Harrap, K.R., et al.. (1971). SITES OF ACTION OF AMETHOPTERIN: INTRINSIC AND ACQUIRED DRUG RESISTANCE. Annals of the New York Academy of Sciences. 186(1 Folate Antago). 312–324. 1 indexed citations
7.
Hart, L. I., et al.. (1970). The composition of milk xan-thine oxidase.. 116(5). 1 indexed citations
8.
Hart, L. I., et al.. (1970). The composition of milk xanthine oxidase. Biochemical Journal. 116(5). 851–864. 140 indexed citations
9.
Hart, L. I. & Robert C. Bray. (1967). Improved xanthine oxidase purification. Biochimica et Biophysica Acta (BBA) - Enzymology. 146(2). 611–613. 24 indexed citations
10.
Hart, L. I., et al.. (1967). The influence of dietary molybdenum on the xanthine oxidase activity of the milk of ruminants. British Journal Of Nutrition. 21(3). 617–630. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026